Award
NIH Reporter #5R33HL167909-03
A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations
Recipient
UT Southwestern Medical Center
Award Amount
$789,365.00
Ceiling
$789,365.00
Awarded
September 01, 2026
Identifier
5R33HL167909-03
Funding supports a clinical trial investigating whether escitalopram can reduce asthma exacerbations and improve asthma control in adults with frequent exacerbations.
Description
A two-phase clinical trial comparing escitalopram with placebo in adults with moderate to severe persistent asthma and frequent exacerbations. The study will assess steroid-burst need, asthma control, functioning, quality of life, and related measures.